Current
99.85 €
+5.11% today
Start price
321.00 €
Target price
400.00 €
+67.9% to target
End price
238.20 €
Performance (%)
-25.79%
Return to target
+67.9%
Confidence
70%
Time horizon
2022-11-28
Performance since start
How it ranks
- #427 Rank 427 of 483 by performance
- 426 ratings for this instrument performed better
- 9 other running ratings for this instrument
Summary
This prediction ended on 12.12.21 with a price of €238.20. The price of BioNTech SE ADR has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -25.79%. Ellritze has 70% into this prediction
Investment thesis
Pros and cons by Ellritze
For
Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
Standard Investments for future growth
Capable Management
Differentiated customer and product portfolio
Against
Higher risks for its business
High valuation
Timeline & discussion
Reasoning and updates for this rating
The discussion is visible to sharewise members.
2 comments are waiting for you.